Citations with the tag: HIV (Viruses)
Results 51 - 100
- High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients.
Pang, S.; Koyanagi, Y. // Nature; 1/4/1990, Vol. 343 Issue 6253, p85
Modifies the PCR method in order to study the amount and form of HIV-1 DNA primary tissue of AIDS patients. Methods; Results; Discussion.
- Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek, T.D.; Lambert, D.M. // Nature; 1/4/1990, Vol. 343 Issue 6253, p90
Demonstrates that synthetic peptide analogues, which are potent inhibitors of purified HIV-1 protease, inhibit the processing of the viral polyproteins in cultures of HIV-1-infected T lymphocytes and attenuate viral infectivity. Methods; Results; Discussion.
- Serine phosphorylation-independent down regulation of cell-surface CD4 by nef.
Garcia, J.V.; Miller, A.D. // Nature; 4/11/1991, Vol. 350 Issue 6318, p508
Expresses the `nef' gene of human immunodeficiency virus type 1 (HIV-1) in three lymphocytic cell lines expressing CD4 using a Moloney murine leukemia virus-based retroviral vector. Experimental methods; Results; Discussion.
- Do antibodies enhance the infection of cells by HIV?
Bolognesi, D.P. // Nature; 8/10/1989, Vol. 340 Issue 6233, p431
Examines the mechanisms by which human immunodeficiency virus (HIV) can enter cells other than by the conventional mechanisms of attachment of HIV to CD4. Process.
- Biological properties of a CD4 immunoadhesin.
Byrn, R.A.; Mordenti, J. // Nature; 4/12/1990, Vol. 344 Issue 6267, p667
Demonstrates that a CD4 immunoadhesin can mediate antibody-dependent cell-mediated cytotoxicity towards human immunodeficiency virus (HIV)-infected cells. Methods; Results; Discussion.
- Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.
Buonocore, L.; Rose, J.K. // Nature; 6/14/1990, Vol. 345 Issue 6276, p625
Demonstrates that expression of a soluble CD4 molecule, mutated to contain a specific retention signal for the endoplasmic reticulum, blocks secretion of gp120 and surface expression of gp120/41, but does not interfere with transport of wild-typeCD4.
- Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate, C.; Zapp, M.L. // Nature; 6/14/1990, Vol. 345 Issue 6276, p640
Presents research reporting that HIV-1 Tat protein can activate transcription when bound to nascent RNA through the RNA-binding domain of another HIV-1 protein, Rev. Methods; Results; Discussion.
- Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity.
Braddock, M.; Thorburn, A.M. // Nature; 4/4/1991, Vol. 350 Issue 6317, p439
Demonstrates that Tat activation of its target RNA in the nucleus involves a Tat-dependent covalent modification. Also finds that the nucleoside analogue 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole blocks this Tat-dependent modification.
- Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
Aldovini, A.; Young, R.A. // Nature; 6/6/1991, Vol. 351 Issue 6326, p479
Reports that a variety of human immunodeficiency virus (HIV) type 1 polypeptides can be expressed in `Mycobacterium bovis' bacillus Calmette-Guerin (BCG) recombinants under the control of mycobacterial hsp70 promoter. Foreign polypeptides produced in BCG can induce antibody and T-cell responses.
- The spread of HIV-1 in Africa: Sexual contact patterns and the predicted demographic impact of AIDS.
Anderson, R.; May, R.M. // Nature; 8/15/1991, Vol. 352 Issue 6336, p581
Examines the spread of the human immunodeficiency virus type 1 (HIV-1) in Africa. Epidemiology in Africa; Epidemiological parameters; Sexual behavior; Mathematical models; Discussion.
- HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
Bachelerie, F.; Alcamo, J. // Nature; 4/25/1991, Vol. 350 Issue 6320, p709
Demonstrates that chronic human immunodeficiency virus (HIV) infection results in both induction of a nuclear factor with antigenic properties indistinguishable from those of NF-kappa B and permanently increased HIV enhancer activity. This phenomenon is associated with HIV replication and may...
- Human infection by genetically diverse SIVsm-related HIV-2 in West Africa.
Gao, Feng; Yue, Ling // Nature; 8/6/1992, Vol. 358 Issue 6386, p495
Relates that our understanding of the biology and origins of HIV-2 derives from studies of cultured isolates from urban populations experiencing epidemic infection and disease. Tests the hypothesis that such isolates might represent only a subset of a larger, more genetically diverse group of...
- Research presents hope for stopping HIV.
Gao, Feng; Yue, Ling // Modern Healthcare; 6/24/96, Vol. 26 Issue 26, p88
Reports on the optimism of researchers that the HIV virus can be eradicated. Discussion of clinical trials demonstrating viral suppression at a conference held in June 1996; Factors for researchers' optimism.
Gao, Feng; Yue, Ling // Advocate; 12/12/95, Issue 696, p39
Presents advice on how actively HIV reproduces and the chances of developing AIDS. Design of tests that measure the amount of virus being produced by HIV-infected cells.
- Court gives virus equal rights.
Gao, Feng; Yue, Ling // Human Events; 07/10/98, Vol. 54 Issue 26, p1
Reports on the court case Bragdon v. Abbott in the Supreme Court of the United States, in which a dentist was charged with violating the rights of a human immunodeficency virus (HIV) patient. Circumstances surrounding the case; Comments from Sidney Abbott, patient; Reference to the Americans...
- Priority on HIV.
Gao, Feng; Yue, Ling // Nature; 11/30/1989, Vol. 342 Issue 6249, p462
Opinion. Discusses a report in the `Chicago Tribune' by journalist John Crewdson concerning who first discovered the virus responsible for AIDS. Robert Gallo of the United States has been given too much credit and French researcher Montagnier too little credit. Report resurrects the...
- Is there a `successful' immune response to HIV?
Brown, Phyllida // New Scientist; 7/4/92, Vol. 135 Issue 1828, p18
Reports on research by scientists at the National Cancer Institute that have begun small-scale studies on the immune systems of people who have been repeatedly exposed to HIV without apparently becoming infected. Men studied; Findings; Conclusion; Discovery of the crystal structure of the HIV's...
- Breaking the news: `You've been exposed to HIV'
Brown, Phyllida // Glamour; Aug97, Vol. 95 Issue 8, p118
Presents information on an East Saint Louis, Illinois man who transmitted the Human immunodeficiency virus (HIV) to more than 100 women. Efforts of the Centers for Disease Control and Prevention; Role of Annie C. Howerton-Privott of the Centers for Disease Control and Prevention.
- Genetic organization of a chimpanzee lentivirus related to HIV-1.
Huet, T.; Cheynier, R. // Nature; 5/24/1990, Vol. 345 Issue 6273, p356
Describes the molecular cloning and sequencing of an infectious proviral clone of SIVCPZ lentivirus. Findings indicate that there is a larger pool of simian lentiviruses than previously suspected and revives the debate as to the origins of HIV-1.
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
Pauwels, R.; Andries, K. // Nature; 2/1/1990, Vol. 343 Issue 6257, p470
Investigates new anti-HIV (human immunodeficiency virus) compounds with acceptable pharmacology. Methods; Results; Discussion.
- Processing of the precursor of NF-kB by the HIV-1 protease during acute infection.
Riviere, Y.; Blank, V. // Nature; 4/18/1991, Vol. 350 Issue 6319, p625
Demonstrates that the human immunodeficiency virus type 1 (HIV-1) protease can process 105K precursor and increases in levels of active nuclear NF-kB complex. Experimental methods; Results; Discussion.
- Danger at the border.
Riviere, Y.; Blank, V. // Advocate; 5/16/95, Issue 681, p14
Reports that four more potent strains of human immunodeficiency virus (HIV) that millions have already contracted in Asia and Africa will soon come to the United States. Warning aired in a Boston conference by Harvard AIDS Institute chairman Max Essex; Identification of the strains and modes of...
- Living proof: Thinking positive.
Riviere, Y.; Blank, V. // Seventeen; Dec92, Vol. 51 Issue 12, p48
Profiles people who are HIV-positive, their positive attitudes and how they are dealing with the diagnosis. Vanessa Clark, 25; Mary Hanerfeld; David Haney, 34; More.
- A plague ignored.
Zimmerman, Carlota // Russian Life; May97, Vol. 40 Issue 5, p6
Reports that as of March 1997, there were 3,327 officially reported cases of HIV-infection in Russia. Information on Gennady Roshchupkin, an AIDS activist and an AIDS victim; Activities of Russians which are putting them at danger of contracting the disease; When the first case of HIV was...
- Tanzania plans to establish a special fund for HIV/AIDS.
Zimmerman, Carlota // African Business News; 4/26/2013, p19
The article reports on the plan of Tanzania to create a special fund for human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) that will lead to a decline in its dependence on external donors by half.
Zimmerman, Carlota // Time International (South Pacific Edition); 03/04/96, Issue 10, p14
Reports on the controversies over the use of human immunodeficiency virus (HIV) tainted blood in Tokyo, Japan. Reference to a file which was revealed by Health and Welfare Minister, Naoto Kan; Number of Japanese who were infected with HIV after the use of the HIV-infected blood; Comments from...
- `Dad, I'm HIV positive.'
Schoch, Russell // Newsweek; 8/17/1992, Vol. 120 Issue 7, p9
Opinion. Examines the author's reaction to the news that his hemophiliac son had contracted the HIV virus. Why he and his son strongly support the effort to re-examine the hypothesis that HIV causes AIDS; Determination to help his son live a life that is as long and as full as it can be.
- HIV funds dry up.
Schoch, Russell // New Scientist; 1/11/92, Vol. 133 Issue 1803, p16
Reports that health officials in cities across the United States fear they may run out of funds for HIV testing within weeks. Demand for testing which rose after Earvin `Magic' Johnson announced he was infected; Cities affected; Number of calls daily at the CDC's National AIDS Hotline.
- The sugarcoated virus.
Gadsby, P. // Discover; Jul88 Supplement, Vol. 9 Issue 7, p30
Examines the AIDS virus' outer membrane. How the glycoproteins confuse the body's immune system infect cells and pose new problems for developing a vaccine.
- Diversity equals death.
Nowak, R. // Discover; May92, Vol. 13 Issue 5, p16
Presents a new theory from two mathematical biologists, Robert May and Martin Nowak of Oxford University, who say that the human immunodeficiency virus (HIV) causes AIDS by quickly diversifying into more strains than the body's immune system can handle. Analysis of HIV-infected immune system as...
- Aids update.
Geraci, Ron; Swierczynski, Duane // Men's Health; Feb97, Vol. 12 Issue 1, p33
Presents an update about AIDS. Undetectable HIV in women's vaginal secretions; Importance of exercise for HIV patients; Drug for treating `wasting syndrome'; Why patients suffering from HIV related symptoms should tell physicians about their sexual history.
- France will compensate.
Aldhous, P. // Nature; 12/12/1991, Vol. 354 Issue 6353, p425
Announces that the French government, bowing to public and media pressure, will provide compensation to about 7,000 citizens who have been infected with human immunodeficiency virus (HIV) through blood products and transfusions. Reaction of Bruno de Langre, president of the French Haemophila...
- Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
Phillips, R.E.; Rowland-Jones, S. // Nature; 12/12/1991, Vol. 354 Issue 6353, p453
Discusses a longitudinal study of human immunodeficiency virus (HIV) seropositive patients in which there were fluctuations in the specificity of cytotoxic T cells for the virus. Describes detailed investigations of cytotoxic T lymphocytes (CTL) recognition of `gag' in six individuals, all of...
- Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.
Ward, R.H.R.; Capon, D.J. // Nature; 8/1/1991, Vol. 352 Issue 6334, p434
Investigates whether soluble CD4 analogues can protect an individual from challenge with human immunodeficiency virus (HIV). Uses a chimpanzee model system of cell-free HIV infection; Results; Discussion.
- Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.
Putkonen, P.; Thorstensson, R. // Nature; 8/1/1991, Vol. 352 Issue 6334, p436
Investigates whether a transfer of antibodies can prevent human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus of sooty mangabey origin (SIVsm) infection in cynomolgus monkeys. Experimental methods; Results; Discussion.
- HIV replication.
Putkonen, P.; Thorstensson, R. // Presidents & Prime Ministers; Jul/Aug96, Vol. 5 Issue 4, p36
Reports on the results of a study which found that activation of the immune system by other stimuli boosts HIV replication.
- Caring for people with AIDS in rural Africa.
Chaava, Thebisa Hamukom // World Health; Sep/Oct96, Vol. 49 Issue 5, p18
Relates how communities and families shares responsibility with local hospitals for caring for people with HIV and Acquire Immune Deficiency Syndrome (AIDS) in several rural areas of Africa. Keys to both care and prevention; How Salvation Army Hospital in rural Zambia responded to the challenge...
- The AIDS puzzle.
Chaava, Thebisa Hamukom // Current Health 1; Nov97, Vol. 21 Issue 3, p6
Focuses on how an individual can help in combating the spread of human immunodeficiency virus (HIV) which leads to acquired immune deficiency syndrome (AIDS). Identification of how a person can get infected with HIV; Indication that by teaching people how HIV infections start and by getting...
- A TIMELINE.
Chaava, Thebisa Hamukom // Xtra (Toronto); 5/31/2012, Issue 720, p20
The article chronicles events concerning HIV/AIDS and Toronto People with AIDS Foundation (PWA) in Ontario including the establishment of the PWA Coalition in 1986, released of the first anti-HIV drug, AZT in 1987 and opening of the fifth international AIDS Conference in Montreal, Quebec in 1989.
- Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression.
Laurence, Jeffrey; Hodtsev, Andrew S. // Nature; 7/16/1992, Vol. 358 Issue 6383, p255
Presents evidence that human CD4 T-cell lines expressing selected T-cell antigen receptor V beta gene products can all be infected in vitro with HIV-1, but give markedly different titres of HIV-1 virion production. Pathogenesis of AIDS; More.
- Bad blood.
Laurence, Jeffrey; Hodtsev, Andrew S. // New Scientist; 4/18/92, Vol. 134 Issue 1817, p11
Reveals that five to ten times as many people have been infected with HIV after a blood transfusion in France than in neighboring countries. Reasons for the difference; Trial of four people charged in connection with France's blood transfusion scandal has been set for June 22.
- A highly divergent HIV-2-related isolate.
Dietrich, U.; Adamski, M. // Nature; 12/21/1989, Vol. 342 Issue 6252, p948
Describes a human immunodeficiency virus type 2 (HIV-2)-related isolate, HIV-2D205, from a healthy Ghanaian woman that is genetically equidistant to the prototypic HIV-2 strains and to sooty mangabey virus (SIVsm) and the simian immunodeficiency virus from rhesus macaques (SIVmac). Methods;...
- Rushed HIV testing risks false results.
Brown, Phyllida // New Scientist; 9/18/93, Vol. 139 Issue 1891, p5
Cites the concern of Public Health Laboratory Service (PHLS) scientists regarding the noncompliance of British laboratories to HIV testing guidelines. Testing for life insurance companies; Chances of errors due to time pressure; Cases of `false positive' results.
- Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.
Anderson, R.; Gupta, S. // Nature; 3/28/1991, Vol. 350 Issue 6316, p356
Demonstrates, through the use of mathematical models, that community treatment with antiviral drugs or immunotherapies that lengthen the incubation period of AIDS without reducing the infectiousness of treated individuals, can increase the rate atwhich HIV-1 infection spreads and can increase...
- Babies who beat AIDS.
Anderson, R.; Gupta, S. // Discover; Jun96, Vol. 17 Issue 6, p30
Reports on HIV-infected children who somehow rid themselves of the virus. Inheritance of maternal antibodies; Proof of infection; Search for fragments of the virus itself; Possible explanations on how the children were able to beat AIDS.
- State Department drops ban on HIV-positive diplomats after pressure from lawsuit.
Anderson, R.; Gupta, S. // Gay & Lesbian Times; 2/21/2008, Issue 1052, p18
The article reports on the decision of the U.S. State Department to take HIV from the list of medical conditions that can prevent foreign service candidates from meeting an employment requirement.
- CDC Advocates Routine Testing and Counseling â€” But Only If Confidential.
Walter, Dave // Advocate; 9/29/87, Issue 482, p17
Reports on the guidelines issued by the Centers for Disease Control on HIV antibody testing in the U.S. Use of routine testing and counseling to encourage safer sex behavior; Controversial issues addressed by the guidelines.
- How long does HIV survive?
M.O.R. // Cortlandt Forum; 12/20/95, Vol. 8 Issue 12, p72
Focuses on how long the human immunodeficiency (HIV) virus survives outside the human body. Disinfectant for HIV.
- French HIV tests.
M.O.R. // New Scientist; 4/11/92, Vol. 134 Issue 1816, p12
Reveals that the French health ministry has ruled out any form of compulsory HIV testing. Instead it has launched a new campaign to encourage voluntary screening; National bodies that were consulted; How they will encourage voluntary screening.
- Anonymous no more.
M.O.R. // Advocate; 9/20/94, Issue 664, p15
Reports on the decision of the North Carolina state health department to require HIV antibody test subjects to furnish their names and address on a confidential basis.